|
|
Meningeal lymphatic dysfunction in traumatic brain injury: roles in disease pathogenesis andlong-term outcomes. |
| 5F30AG069396-03 |
|
NIA |
2022 |
|
|
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial |
| 5U01AG060965-04 |
|
NIA |
2022 |
|
|
TFEB-mediated lysosome-to-nucleus signaling in aging and lifespan regulation |
| 1 P01 AG066606-01A1 |
|
NIA |
2021 |
|
|
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction |
| 1 R01 AG069906-01A1 |
|
NIA |
2021 |
|
|
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer’s disease |
| 1 R01 AG075820-01 |
|
NIA |
2021 |
|
|
Impact of the Human Herpesvirus 6A (HHV6A) latency gene U94A on Alzheimer disease pathology |
| 1 R01 AG075978-01 |
|
NIA |
2021 |
|
|
The role of Chlamydia pneumoniae infection in Alzheimers Disease |
| 1 R01 AG075998-01 |
|
NIA |
2021 |
|
|
Effects of cell-type specific brain stimulation in Alzheimer's model mice |
| 1 R03 AG070517-01 |
|
NIA |
2021 |
|
|
Contribution of Endothelial Changes and Increased Cardiovascular Risk to Alzheimers Disease Pathogenesis |
| 1 R03 AG070541-01A1 |
|
NIA |
2021 |
|
|
Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation |
| 1 R03 AG073829-01 |
|
NIA |
2021 |
